Image

The Role of the Pulmonary Vasculature in the Fontan Circulation

The Role of the Pulmonary Vasculature in the Fontan Circulation

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

This study aims to explore the structural and functional characteristics of the pulmonary vasculature in adult Fontan patients.

Objectives
  • Determine the effect of pulmonary vasodilatation on indexed cardiac output during simulated exercise.
  • Characterization of structural properties of small pulmonary arteries.

Description

Rationale

The Fontan circulation is a palliation for patients with a functionally univentricular heart. The Fontan circulation is characterized by impaired exercise capacity and gradual attrition over time. To date treatment options are extremely limited. It has been proposed that pulmonary vascular resistance (PVR) is the controlling and limiting factor of cardiac output in the Fontan circulation. Remodeling of the pulmonary vasculature and increasing PVR are possible key factors in the long term failure of the Fontan circulation. Optical Coherence Tomography (OCT) is an intravascular imaging modality used for structural characterization of blood vessels. Nitric oxide is a pulmonary vasodilator used in pulmonary vascular response tests, aimed at lowering PVR which may improve cardiac output in the Fontan circulation. These two diagnostic procedures are tools to study the structural and functional characteristics of the pulmonary vasculature in the Fontan circulation. The results of this study could identify the pulmonary circulation as a future treatment target in Fontan patients and may provide clues for new therapeutic treatment strategies to improve the long term outcome of these patients.

Study procedure:

The study protocol will be performed during a clinically indicated cardiac catheterization. In the context of this study additional measurements will be performed which will include a pulmonary vascular response test, trans-thoracic echocardiography and pulmonary artery OCT measurements.

Eligibility

Inclusion criteria:

Fontan group

  • written informed consent
  • Clinical indication for cardiac catheterization

Control group

  • written informed consent
  • Clinical indication for right heart catheterization
  • Absence of pulmonary vascular disease
  • Normal pulmonary vascular hemodynamic profile

Exclusion criteria:

Fontan group

  • Standard exclusion criteria for cardiac catheterization
  • Obstruction in Fontan conduit
  • Inability to measure a reliable cardiac index and PVR (rhythm instability, hemodynamic or anatomic reasons)

Control Group

  • No specific exclusion criteria apart from the standard exclusion criteria for right heart catheterization.

Study details
    Congenital Heart Disease
    Fontan Operation
    Pulmonary Vascular Resistance
    Pulmonary Vascular Remodeling

NCT02414321

University Medical Center Groningen

27 January 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.